Innoviva Specialty Therapeutics News and Activities

Innoviva Specialty Therapeutics is owned by Innoviva.

Innoviva is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Innoviva is a company listed under the stock ticker INVA (US).

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 10 main executives

Most searched biographies at Innoviva Specialty Therapeutics

• Steve Basso, President
• David Altarac, Chief Medical Officer
• Patricia Drake, Chief Commercial Officer

Popular executive movements at Innoviva Specialty Therapeutics

• Maggie Beaudoin has joined the company as Vice President of Finance  (posted on February 11 2026).

Popular executive movements at Innoviva

• Derek Small, Director, has left the company  (posted on May 19 2026).
• Josephine Linden has joined the company as Director  (posted on May 19 2026).
• Mark DiPaolo, Chairman of the Board, has left the company  (posted on May 19 2026).

Create your alert
to follow the executive moves at Innoviva Specialty Therapeutics.

Innoviva has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by Innoviva Specialty Therapeutics

Social media about Innoviva Specialty Therapeutics

• Innoviva Specialty Therapeutics on Wikipedia, Google News & Yahoo Finance
• Innoviva Specialty Therapeutics on LinkedIn, X (Twitter) & YouTube